EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Outcomes and complications of biliary drainage for malignant biliary obstruction: National prospective study

Philip R Harvey, Richard Rj Wilkin, Shahd A Mohamed iD, Sarah Powell-Brett, Siobhan C McKay, Georgia R Layton, Keith Roberts, Nigel Trudgill

Endoscopy International Open · 23.07.2025 · 13 (CP)

DOI: 10.1055/a-2558-6754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 23.07.2025. Verfasst von Philip R Harvey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom of Great Britain and Northern Ireland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Midlands Gastroenterological Society, Pancreatic Cancer UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

National data suggest that biliary drainage for malignant obstruction is associated with high complication rates and early mortality. This study examined factors associated with poor outcomes. RICOCHET was a national, prospective audit of patients with pancreatic cancer or malignant biliary obstruction between April and August 2018. This analysis reviewed outcomes including complications within 7 days and 30-day mortality following biliary drainage and associated factors. Biliary drainage was attempted in 773 patients, of which, 78.7% were successful at first attempt; but if unsuccessful, only 37% of subsequent attempts succeeded. Complications occurred following 11% of endoscopic retrograde cholangiopancreatographies (ERCPs) (including pancreatitis, 5%) and 12% of percutaneous transhepatic biliary drainages (PTBDs) (including cholangitis, 8%). Complications were associated with: potentially resectable cancer (odds ratio [OR] 1.93, 95% confidence interval [CI] 1.23–3.03); more than one biliary drainage attempt (OR 1.69, 95% CI 1.04–2.74); cholangiocarcinoma (OR 2.20, 95% CI 1.20–4.05), or radiological cancer diagnosis (OR 2.02, 95% CI 1.13–3.60). Thirty-day mortality rates following ERCP and PTBD were 21.4% and 21.4%, respectively, in unresectable cancer and 6% and 6.3%, respectively, in potentially resectable cancer. Increased 30-day mortality in patients with unresectable disease was associated with a performance status of 2 or more (HR 3.14 (1.65–5.97)). Thirty-day mortality was significantly higher in patients with unresectable cancer if a multidisciplinary team meeting had not reviewed and advised drainage prior to the procedure 50% vs 20.4% (P = 0.028). Careful multidisciplinary consideration of risks and potential benefits should be undertaken prior to attempting malignant biliary drainage due to the high risk of complications and early mortality.

Schlagwörter

Stichwörter der Autor:innen

CholangiopancreatographyCholangiopancreatography Endoscopic RetrogradeEndoscopic Retrograde/adverse effectsMortalityPercutaneous Transhepatic Biliary DrainagePercutaneous Transhepatic Biliary Drainage/complications

Autor:innen und Institutionen

  • Gastroenterology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom of Great Britain and Northern Ireland.
  • General Surgery, Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom of Great Britain and Northern Ireland.
  • Gastroenterology, Sandwell and West Birmingham NHS Trust, West Bromwich, United Kingdom of Great Britain and Northern Ireland.
  • Department of Hepatopancreatobiliary Surgery and Liver Transplantation, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom of Great Britain and Northern Ireland.
  • Department of Cardiothoracics, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom of Great Britain and Northern Ireland.
  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom of Great Britain and Northern Ireland.

ORCID-Profile: Shahd A Mohamed

Förderung

  • Midlands Gastroenterological Society
  • Pancreatic Cancer UK

Zitieren

APA

Harvey, P. R., Wilkin, R. R., Mohamed, S. A., Powell-Brett, S., McKay, S. C., Layton, G. R., Roberts, K., & Trudgill, N. (2025). Outcomes and complications of biliary drainage for malignant biliary obstruction: National prospective study. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2558-6754

Vancouver

Harvey PR, Wilkin RR, Mohamed SA, Powell-Brett S, McKay SC, Layton GR, et al. Outcomes and complications of biliary drainage for malignant biliary obstruction: National prospective study. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2558-6754

BibTeX
@article{Harvey2025,
  author = {Harvey, Philip R and Wilkin, Richard Rj and Mohamed, Shahd A and Powell-Brett, Sarah and McKay, Siobhan C and Layton, Georgia R and Roberts, Keith and Trudgill, Nigel},
  title = {Outcomes and complications of biliary drainage for malignant biliary obstruction: National prospective study},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2558-6754}
}
Kostenlos starten →